Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Transformer-2 alpha pseudogene (ENSG00000223429) is a non-coding genomic locus annotated as a pseudogene, likely derived from a former protein-coding transformer-2 alpha gene. Pseudogenes generally arise from gene duplication or retrotransposition; they accumulate mutations that disrupt their ability to encode a functional protein. Most do not produce functional RNA or protein, though rarely, transcribed pseudogenes may have regulatory effects, such as influencing expression of related protein-coding genes. There is no evidence that this specific pseudogene is a therapeutic target or is involved in clinically relevant mechanisms[1][2][3][4]. Key insights supporting this assessment: - Pseudogenes are distinct from protein-coding genes and typically lack functional products due to disabling mutations[1][2]. - They are classified separately from therapeutic targets; the majority lack translatable biological or disease-related function[1][3]. - "Transformer-2 alpha pseudogene" reflects its derivation from the transformer-2 alpha ancestral gene, but all evidence classifies it as non-functional[4]. - No known drug interactions, mechanisms, or biomarker utility exist for this locus[1][2][3][4]. This entry is therefore best classified as non-target, with "is_incorrect" marked true, because it is not a true therapeutic or biological target under standard classifications.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Transformer-2 alpha pseudogene.